Clinical Trials Logo

Pulmonary Surgical Procedures clinical trials

View clinical trials related to Pulmonary Surgical Procedures.

Filter by:
  • None
  • Page 1

NCT ID: NCT05600569 Recruiting - Lung Neoplasm Clinical Trials

Registry of the Spanish Society of Thoracic Surgery

ReSECT
Start date: January 1, 2023
Phase:
Study type: Observational [Patient Registry]

ReSECT is a project promoted by the Spanish Society of Thoracic Surgery with the aim not only to become an indefinite, dynamic and inclusive registry, but also to establish a common structural framework for the development of future multicentre projects in the field of thoracic surgery in Spain. The goal of this nationwide prospective observational registry is: - To develop and validate forecasting tools based on powerful computational methods with the goal of assisting in decision-making and improving quality of care. - To evaluate the progressive implementation of certain surgical techniques that are on the rise, new technologies and future health programs. - To be aware of our results as specialty and professionals and to serve as a permanent benchmarking instrument in thoracic surgery. The first part of ReSECT, based on a personal registry design, will contemplate any thoracic surgical procedure performed by thoracic surgeons and residents in thoracic surgery in our country. Additionally, the Spanish thoracic surgery departments that voluntarily accept to collectively participate will contribute to specific surgical processes focused on certain procedures with specific objectives to be progressively implemented. The first and only surgical process implemented since the start of the ReSECT project will focus on patients to undergo anatomical lung resection with special interest in those cases whose reason for intervention was lung cancer. The main questions to answer in case of that first surgical process include: - What is the performance of current predictive models for perioperative and oncological outcomes in our country? - How could we modify previous predictive models to improve their performance? - What is the implementation of current guideline recommendations in our country and across institutions? - What is the potential impact of deviations from current recommendations? - What is my performance compared to the rest of the thoracic surgical departments in my country in terms of perioperative and oncological outcomes? ReSECT does not consider prespecified comparison groups of patients.

NCT ID: NCT05126524 Completed - Clinical trials for Pulmonary Surgical Procedures

Loco-regional Anaesthesia in Video or Robot-assisted Thoracic Pulmonary Surgery

ARTIST
Start date: January 4, 2021
Phase:
Study type: Observational

Currently, there is no data on the part and type of Loco-regional Anaesthesia used for Video or Robot-assisted Thoracic Pulmonary Surgery. The aim of this epidemiological study is to identify, 6 months after the publication of the SFAR / SFCTCV 2019 recommendations, the proportion and type of Loco-regional Anaesthesia used in Video or Robot-assisted Thoracic Pulmonary Surgery within French teams.

NCT ID: NCT03418090 Completed - Clinical trials for Pulmonary Surgical Procedures

Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung Transplant

Start date: August 17, 2018
Phase: Phase 3
Study type: Interventional

This study compares the equivalence of hyperpolarized 129Xe MRI to 133Xe scintigraphy for the evaluation of pulmonary function in patients being evaluated for lung transplant.

NCT ID: NCT03417687 Completed - Clinical trials for Pulmonary Surgical Procedures

Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung Resection

Start date: August 17, 2018
Phase: Phase 3
Study type: Interventional

This study compares the equivalence of hyperpolarized 129Xe MRI as compared to 133Xe scintigraphy for the evaluation of pulmonary function in patients being evaluated for lung resection.

NCT ID: NCT02376218 Completed - Clinical trials for Pulmonary Surgical Procedures

Post-lobectomy Use of Glucose for Pleurodesis and Air-leak Cessation. A Feasibility Trial.

PLUG
Start date: April 2015
Phase: N/A
Study type: Interventional

It is common practice to leave a chest drainage catheter after lung surgical resections to manage air leaks. The air leakage will usually stop in the initial postoperative days, but in a few patients, it will last for a longer period of time, preventing the removal of the chest tube that can lead to patient discomfort, increased likelihood to develop postoperative complications and longer length of hospital stay. Pleurodesis is an effective method to address postoperative air leak which consists in injecting an irritating solution into the chest cavity. This is not performed regularly after lung resections for different reasons including associated pain, costs, and fear of infections. Pleurodesis with hyperosmolar glucose solution have been used for years with good results in some Asian countries because of its simplicity and low cost. Its effectiveness for pleurodesis has been reported in cases of spontaneous pneumothorax and chylothorax, but its efficiency to stop air leaks in the postoperative period remains to be defined.

NCT ID: NCT01255033 Completed - Clinical trials for Pulmonary Surgical Procedures

Oxygen Peripheral Saturations and Lung Surgery

Start date: November 2010
Phase: N/A
Study type: Observational

The purpose of this study is to compare the ability of two peripheral and non invasive devices to detect hypoxic events during one-lung ventilation and during the early postoperative period. One device measures regional cerebral oxygenation and the other muscular oxygenation. These two devices are compared to non invasive arterial saturation (SpO2), which is the gold standard.

NCT ID: NCT00925444 Completed - Lung Neoplasms Clinical Trials

Staple-line Reinforcement for Prevention of Pulmonary Air Leakage

SPIRAL
Start date: June 2009
Phase: Phase 4
Study type: Interventional

The aim of this study is to compare the efficacy of FORESEAL with stapling alone or associated with tissue sealant or glue in terms of air leakage duration after lung resection for cancer. Hypothesis: to show a significant difference of 1 day in the average duration of air leakage between the 2 groups with a standard deviation of 3 (α =0.05 and β=0.10).